Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0027627 (metastases)
 103,950 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A retrospective review of 498 patients with 584 skin cancers occurring on the head and seen between 1971 and 1976 is reported. All were treated by radiotherapy. There were 433 basal cell and 151 squamous cell carcinomas for a ratio of 2.9:1. The median age for developing skin cancer was 69 (22-92) years and there was a male to female advantage of approximately 1.5:1. Overall, the primary tumor was controlled at three years in 553 instances (94.7%). None of the basal cell carcinomas metastasized. Cervical node metastases developed in 12 patients (8%) with squamous cell carcinoma. Overall there were four (0.8%) tumor related deaths.
 ...
PMID:Skin cancer of the head--treatment by radiotherapy. 643 42

Merkel cell carcinoma, also known as endocrine carcinoma of the skin, is a recently recognized and particularly aggressive form of skin cancer that exhibits histologic features similar to those of endocrine malignant neoplasms arising from other tissues. Forty-one patients with Merkel cell carcinoma arising from the cutaneous surfaces of the head and neck were seen at the University of Texas M. D. Anderson Hospital, Houston, between 1966 and 1983. Regional lymph node metastasis occur early and frequently, with a 79% overall incidence observed during the course of the disease. Treatment should consist of a wide resection of the primary tumor. A regional lymphadenectomy, when feasible, is successful in controlling nodal metastases. Postoperative radiation is recommended as an important adjuvant.
 ...
PMID:Merkel cell carcinoma (endocrine carcinoma of the skin) of the head and neck. 648 23

Between 1956 and 1978, 4820 kidney transplantations were performed in 3959 patients in Scandinavia. In 18 cases the transplantation was performed in patients with a prior malignant tumour. There were 11 cases of tumours of the urinary tract. 3 cases of skin cancer and 4 of tumours in other organs. The observation period was 1-108 months before transplantation and 3-77 months after transplantation. In 14 cases it was possible to make a paired prognostic evaluation between the tumour patient and the recipient of the contralateral kidney from the same donor. On this basis, it was concluded that provided the recipient is observed for about 1 year after the treatment of a tumour and no signs of metastases are seen before transplantation, the previous malignancy does not seem to vitiate the prognosis for the course of the transplantation.
 ...
PMID:The fate of kidney-transplanted patients with a previous history of malignancy. The Scandinavian material. 676 63

During the period from 1955 to 1974, a total of 23 cases of skin cancer in indigenous Greenlanders was diagnosed, 15 in males and eight in females. There were ten basal cell carcinomas, four squamous-cell carcinomas, five malignant melanomas of the skin, and four sarcomas. Eight of the ten basal cell carcinomas were located on the head, half of these on the eyelids. Three of the four squamous-cell carcinomas were found on the lower lip. The number of malignant melanomas in females and the number of remaining, nonmelanotic skin cancers in both males and females were significantly lower than expected if the incidence in the Greenland population had been the same as in Denmark. Since recent investigations seem to indicate that the annual ultraviolet radiation is of almost the same magnitude as in northwest Europe, the low incidence may be due to less skin exposure and/or ethnic factors such as a higher degree of pigmentation. No accumulation of cases within definite geographical areas was found and no occupational clustering was apparent. As regards both squamous-cell carcinomas and malignant melanomas, the degree of metastases and survival indicated that Greenlandic patients sought medical assistance very late.
 ...
PMID:Skin cancer in Greenland 1955-1974. 683 43

Skin cancers originating in areas of chronic injury (Marjolin's ulcers) are thought to behave in a more aggressive fashion than those due to other causes. The initial surgical treatment, especially the management of the regional lymph nodes, remains controversial. This review of 37 patients with Marjolin's ulcer evaluated the effectiveness of local surgical treatment at our center. Three of 18 patients treated with amputation developed recurrences and died of metastatic disease. Five of 16 patients treated by wide excision developed recurrences, two dying with metastatic disease, the remaining three apparently cured by additional surgery. Only six (17.6%) of the patients treated by "local" modalities, i.e., wide excision or amputation, developed subsequent regional node metastases. Recurrences following local excision tend to be local and can usually be managed by re-excision or amputation. It can be inferred from this study that prophylactic node dissections are not required in most patients with Marjolin's ulcers.
 ...
PMID:Marjolin's ulcer. The LSU experience. 685 May 40

Out of 420 kidney transplant recipients at the University Hospital, Zurich, operated on between 1964 and 1978, 23 developed one or more malignant tumors. This corresponds to 5.8% of all patients. They included 8 cases of malignant lymphoma (non-Hodgkin), one of subacute myeloic leukemia, one of acute lymphatic leukemia, 6 skin cancers and 9 cancers of internal organs. Thirteen patients died, a figure corresponding to 8% of all deaths after kidney transplantation. Nine of the 10 patients with lymphoma and leukemia died, in 5 cases despite therapy. The response to therapy (radiotherapy and/or chemotherapy) was much poorer than in other patients with comparable tumors and in some patients completely absent. The only surviving patient (malignant lymphoma of the small bowel and the retroperitoneum) was treated by a combination of surgery, radiotherapy and chemotherapy and has had a symptom-free follow-up time of 3 1/2 years. The 6 skin cancers (4 of the spinocellular type) were excised. Recurrences were not noted. The visceral carcinomas (2 breast cancers, 1 carcinoma respectively of the pancreas, the rectum, the liver, the kidneys, the renal pelvis, and the urinary bladder, and one seminoma) were treated by generally accepted surgical principles as far as treatment of the patients was possible. The breast cancer and seminoma patients have survived thus far without recurrences or metastases.
 ...
PMID:[Malignant tumors in bearers of kidney grafts in immunosuppressive therapy]. 703 60

Involvement of the parotid gland or periparotid nodes by direct extension from a skin cancer or metastasis from a present or previously treated skin cancer is an uncommon but potentially disastrous event. Aggressive surgery with sacrifice of necessary structures but preservation of the facial nerve and surrounding structures when feasible results in satisfactory local and regional control. The overall local or regional control rate was 70.9 percent. Isolated metastases to the parotid gland in patients with successfully treated nonbasal cell skin cancers are controlled locally or regionally in 84.2 percent of the 57 patients reviewed. The addition of radiotherapy should be considered in patients when warranted by the pathologic findings and clinical condition of the patient, however, it is not without complications.
 ...
PMID:Role of parotidectomy for skin cancer of the head and neck. 728 48

Sunlight induced squamous cell carcinoma of the skin is common and produces low incidence of metastases. Non-actinic squamous cell carcinoma, however, possesses a metastatic potential even when well differentiated. A representative case of keratinizing squamous cell carcinoma arising in a lower extremity with development of widespread metastases is discussed. The prognostic factors associated with metastasizing de novo squamous cell carcinoma of the extremity include: site of origin, duration of lesion, degree of differentiation, sex of patient, and size of the primary lesion. Organs prone to metastasis include: regional lymph nodes, liver, lungs, and bone. As skin cancers of this variety metastasize, the clinician must recognize this potential when considering therapeutic strategy.
 ...
PMID:Metastatic squamous cell carcinoma of the skin. 731 Sep 7

Identification of antigens by monoclonal antibodies (MAbs) on sections of human melanoma by immunoperoxidase techniques was used to determine whether certain adhesion molecules and "selectin-like" molecules may be related to the metastatic potential of primary melanoma. The adhesion molecules examined were the leukocyte function antigen (LFA-1) and its ligand--intercellular adhesion molecule-1 (ICAM-1), the receptor alpha V beta 3 for vitronectin, its subunits alpha V and beta 3, and the CD36 receptor for thrombospondin (TSP). The criteria used to establish metastatic potential were relation of the molecules to tumor thickness and differences in expression: (i) between radial and vertical growth phases of the primary tumors and (ii) between 34 primary and 21 unrelated metastases. By these criteria ICAM-1, alpha V beta 3 and its subunit were associated with the malignant potential of primary melanoma. These molecules were not expressed on nevi or other skin cancers with low metastatic potential such as squamous (SCC) and basal cell carcinomas (BCC). In contrast, expression of TSP and the CD36 receptor for TSP were not related to metastatic potential. CD36 was expressed widely not only on melanoma but also on BCC, SCC and nevi. Similarly, the selectin-like molecule, CD44, was widely expressed on melanoma and non-melanoma carcinomas. The lymph node homing receptor, Leu 8, and the cutaneous lymphocyte antigen (CLA) were not detected on melanoma. Leu 8 was present on normal epithelium and SCCs, and common leucocyte antigen (CLA) was detected on lymphocytes in the epithelium and near melanoma. These results support previous suggestions that expression of ICAM-1 and V beta 3 integrin or its subunit beta 3 on melanoma may be a useful prognostic marker in primary melanoma. They do not support a role for CD44, Leu 8, CLA and TSP or its receptor CD36 in the metastatic process in melanoma.
 ...
PMID:Immunohistological examination of the relationship between metastatic potential and expression of adhesion molecules and 'selectins' on melanoma cells. 751 76

Electrochemical therapy (ECT) was used for the treatment of 144 cases of soft tissue and superficial malignant tumours. All tumours were cytologically verified and included 39 soft-tissue sarcomas, ten head-neck cancers, 21 malignant melanomas, seven skin cancers, three cervical cancers, two breast cancers, 27 recurrent cancers and 35 metastatic cancers. The TNM stage of primary cancers were: T1: n = 28, T2: n = 36, T3: n = 12, and T4: n = 6. Among these, 23 cases were lymph nodes metastases and 12 systemic metastases. There were 43 cases of localised recurrent cancer and 19 cases of generalised metastatic disease. ECT was used to treat 128 cases once, nine cases twice, four cases three times and three four times. All patients received systemic chemotherapy for one to two cycles, and three of them were also treated by radiotherapy. The short-term effectiveness rate was 86.87% (125/144) with 81 complete response (CR) (tumour disappeared completely), accounting for 58.3% of all cases, 41 partial response (PR) (tumour regressed to more than half of its original size) accounting for 28.5%. Fourteen (9.7%) no change (NC); tumour regressed to less than half of its original size) and five (4.5%) progressive disease (PD); tumour did not regress or even increased in size). The short-term effectiveness rate in relation to tumour size was 94.5% (120/127) for tumour diameters of < 7 cm and 29.4% (5/17) for tumour diameters > 7 cm (p < 0.001). The long-term effectiveness, that is the survival rates for 1, 2, 3 and 4 years, was 83.3% (120/144), 74.1% (89/120), 84.3% (75/89) and 73.3% (55/75), respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Analysis of the clinical effectiveness of 144 cases of soft tissue and superficial malignant tumours treated with electrochemical therapy. 753 Oct 18


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>